Tags: Lilly | Drop | Profit | drug

Lilly Projects Sharp Drop in 2012 Profit

Thursday, 05 Jan 2012 08:26 AM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink

Eli Lilly & Co. forecast a steeper-than-expected decline in profit for 2012, the first full year without exclusive rights to its big-selling Zyprexa schizophrenia treatment.

Shares fell 3.5 percent after Lilly announced its forecast on Thursday.

The drugmaker projected earnings in the range of $3.10 per share to $3.20 per share for 2012. For 2011, Lilly said it expects to meet or exceed its profit forecast of $4.30 per share to $4.35 per share, excluding items. Including items, Lilly sees 2011 earnings per share of $3.84 to $3.89.

Analysts were looking for $3.61 per share in 2012, according to Thomson Reuters I/B/E/S.

Zyprexa, a $4.5 billion-a-year product, began facing competition in October from low-cost generic versions in the United States.

© 2014 Thomson/Reuters. All rights reserved.

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Politico: Obama May Give Dems 80 Percent of 2016 Latino Vote

Friday, 19 Dec 2014 19:18 PM

President Barack Obama may be on track to helping deliver as much as 80 percent of Latino voters to the 2016 Democratic  . . .

Obama Appointee's Group Accused of Illegal Politicking

Friday, 19 Dec 2014 19:09 PM

A nonprofit group run by an Obama administration appointee may have supported Democratic mayoral candidates in Californi . . .

Sens. Rand Paul, Marco Rubio Clash Over Obama's Cuba Policy

Friday, 19 Dec 2014 15:23 PM

Kentucky Sen. Rand Paul took a series of online digs Friday at potential GOP presidential rival Sen. Marco Rubio of Flor . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved